CombiMatrix launches Combimatrix Molecular Diagnostics
CombiMatrix Corporation announced that its subsidiary, Combimatrix Molecular Diagnostics, has completed the clinical validation of its highest density constitutional array genetic test to date, the BAC HD Scan test. Following the successful validation, CombiMatrix has launched the test, which can diagnose over 125 genetic disorders.
- Pathway Diagnostics launches SensiTrop II assay
- Use of Roche Diagnostics Elecsys Anti-HCV assay expanded
- Abbott launches Architect i1000SR analyzer
- FDA’s expanded indication for Chembio’s POC testing
